TP53 and neoplasm: On the other hand, in a hepatocyte-specific knockout mouse model, USP33-deficient mice showed increased sensitivity to DEN-induced hepatocarcinogenesis, suggesting that USP33 may possess anti-tumor activity through regulating p53 stability and activity [37].